Comparison of the injection of low‐molecular weight heparin in the arterial vs. venous blood line for preventing extracorporeal circuit clotting during hemodialysis
Mohamed Belmouaz(Centre de Référence des Maladies Autoinflammatoires et des Amyloses), Frank Bridoux(Université de Poitiers), Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Audrey Sibille(Université de Poitiers), Laure Écotière(Centre National de la Recherche Scientifique), Guillaume Goussard(Université de Poitiers), Antoine Thierry(Université de Poitiers), François Grand(Université de Poitiers), Florent Joly
Cited by 3
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520